# Trade Mark Journal No.2026/030 24 July 2026

## WO0000001911861 (1,5,40,42)

Office of origin: United States of America

Date of International Registration:12 February 2026
Date of designation in the UK: 12 February 2026

International priority date claimed: 5 September 2025 (United States of America) (99376736)

Class 1
  Enzymes for scientific and research purposes; enzyme substrates for scientific purposes; peptide substrates for scientific purposes.
Class 5
  Enzyme preparations for medical purposes; enzymes for medical purposes; enzyme substrates for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates.
Class 40
  Conversion of targeted substrates into targeted chemical preparation by treatment with enzyme systems.
Class 42
  Biotechnology research; research and development in the field of biotechnology; research and development of antibody-drug conjugates; research and development of conjugated antibodies; research and development of drug conjugates; laboratory services for biomanufacturing; laboratory services for biomanufacturing peptides; laboratory services for biomanufacturing enzymes; laboratory services for biomanufacturing peptide substrates; laboratory services for biomanufacturing enzyme substrates.

Ridge Biotechnologies, Inc.

Representative: Scott A. Lund Dicke, Billig & Czaja, PLLC, 100 South Fifth Street, Suite 2250, Minneapolis MN 55402, UNITED STATES OF AMERICA